Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO1117
Host Cell : Ba/F3 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO1117 |
| Description | This cell line is engineered to stably overexpress human MET in Ba/F3 cells. |
| Target Gene | MET |
| Gene Species | Homo sapiens (Human) |
| Host Cell | Ba/F3 |
| Host Cell Species | Mus musculus (Mouse) |
| Applications | Drug screening and biological assays |
| Biosafety Level | 2 |
| Size | >1x10^6 frozen cells/vial, 1 mL |
| Stability | Stable in culture over a minimum of 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Growth Conditions | 37 °C, 5% CO2 |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Thawing & Subculturing Instructions | 1. Thaw cells by gently swirling in a 37°C water bath. To limit contamination, do not submerge the O-ring and cap. 2. When cells are ~70% thawed (~1 min), transfer the vial into a biosafety cabinet, and wipe the surface with 70% ethanol. Allow tube to dry completely. 3. Transfer the cells gently into a 15 mL conical tube containing 10 mL of pre-warmed culture medium (without antibiotic selection marker). Centrifuge cells at ~125 x g for 5~7 min. 4. Remove supernatant without disturbing the pellet, and resuspend cells in 1 mL culture medium (without antibiotic selection marker). Transfer cells to a 6-well plate containing ~2 mL pre-warmed growth medium (without antibiotic selection marker) or a T25 flask containing 5 mL pre-warmed culture medium (without antibiotic selection marker). 5. Incubate the culture at 37°C with 5% CO2. 6. Subculture: split saturated culture 1:4 ~ 1:6 every 3 days; seed out at about 1~3 x 10^5 cells/mL. |
| Freeze Medium | Frozen with 70% medium, 20% FBS, 10% DMSO |
| Growth Properties | Suspension, round |
| Freezing Instructions | Cells are recommended to generate additional frozen stocks at early passages. Frozen stocks should be preserved in a designated cryopreservation medium or in 70% RPMI 1640 + 20% FBS + 10% DMSO (without antibiotic selection marker). 1. Prepare the freezing medium (70% RPMI 1640 + 20% FBS + 10% DMSO, without antibiotic selection marker) fresh immediately before use. 2. Keep the freezing medium on ice and label cryovials. 3. Transfer cells to a sterile, conical centrifuge tube, and count the cells. 4. Centrifuge the cells at 250 x g for 5 minutes at room temperature and carefully aspirate off the medium. 5. Resuspend the cells at a density of at least 3 x10^6 cells/ml in chilled freezing medium. 6. Aliquot 1 ml of the cell suspension into each cryovial. 7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer. 8. Transfer vials to liquid nitrogen for long-term storage. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | MET met proto-oncogene (hepatocyte growth factor receptor) [ Homo sapiens ] |
| Gene Symbol | MET |
| Synonyms | HGFR; AUTS9; RCCP2; c-Met |
| Gene Description | met proto-oncogene (hepatocyte growth factor receptor) |
| GeneID | 4233 |
| Uni ProtID | P08581 |
| mRNA Refseq | NM_000245.2 |
| Protein Refseq | NP_000236.2 |
| Chromosome Location | 7q31 |
| Function | ATP binding; beta-catenin binding; hepatocyte growth factor-activated receptor activity; phosphatidylinositol 3-kinase binding; phospholipase binding; protein binding; protein complex binding; protein heterodimerization activity; protein tyrosine kinase activity; protein tyrosine kinase activity; |
| Pathway | Adherens junction, organism-specific biosystem; Adherens junction, conserved biosystem; Alpha6-Beta4 Integrin Signaling Pathway, organism-specific biosystem; Arf6 signaling events, organism-specific biosystem; Axon guidance, organism-specific biosystem; Axon guidance, conserved biosystem; Axon guidance, organism-specific biosystem; |
| MIM | 164860 |
Stable cell line of human MET The MET gene, which codes for a receptor tyrosine kinase and the byproduct of the proto-oncogene MET, is designed to be expressed in the BaF3 cell line. The mature receptor's alpha and beta subunits are produced via proteolytic processing of the MET preproprotein. Hepatocyte growth factor (HGF) binding causes MET to dimerize and become activated. This process is important for cellular survival, embryogenesis, migration, and invasion.
Numerous malignancies, such as hepatocellular carcinoma, head and neck tumors, and papillary renal cell carcinoma, are linked to mutations in the MET gene. Numerous malignancies in humans have also been connected to MET overexpression and amplification.
A popular murine pro-B cell line in cancer and cell signaling studies is BaF3 cells. To boost their development and survival, they are cultivated on a medium enriched with interleukin-3 (IL-3). Rapidly multiplying suspension cells called BaF3 are frequently employed in research on receptor tyrosine kinase signaling cascades.
Hepatocyte growth factor (HGF) activates the c-MET receptor, which is crucial for tissue regeneration and cellular processes like migration and proliferation. However, the clinical application of HGF is limited due to its instability and poor recombinant expression. The researchers engineered a more stable and expressible HGF fragment, eNK1, and developed a dimerized version of eNK1 that showed significantly improved c-MET activation and cellular responses compared to the monomer. In this study, the researchers used BaF3-MET cells, a murine cell line transfected with human c-MET receptors, to analyze the binding affinity and activity of the eNK1 monomer and dimer. They found that the eNK1 dimer had a much lower IC50, indicating stronger binding affinity. This research highlights the potential of Creative Biogene's Human MET Stable Cell Line - BaF3 as a tool for similar studies on c-MET receptor activation and its implications for regenerative medicine
Figure 1. The researchers treated HUVEC cells with HGF, eNK1 monomer, or eNK1 dimer at various concentrations to assess c-MET activation. They used Western blot analysis to detect phosphorylated c-MET, Akt, and Erk and employed the PathHunter system to quantify c-MET activation through chemiluminescence. BaF3-MET cells were used for binding assays to measure affinity. (Hassannia H, et al., 2022)
1. Cancer Research: Using the human MET stable cell line Ba/F3, we studied the mutation and overexpression of the MET gene in hepatocellular carcinoma, head and neck tumors, and papillary renal cell carcinoma, revealing its specific mechanism in tumor occurrence and development.
2. Drug Screening and Evaluation: Using the Ba/F3 cell model, we tested and evaluated drugs targeting the MET receptor tyrosine kinase, studied its therapeutic effects in different types of tumors, and provided a basis for personalized treatment.
3. Signal Transduction Research: Using the MET stable cell line, we explored the dimerization and activation process of MET after binding to hepatocyte growth factor (HGF), and studied its signal transduction pathways in cell survival, embryonic development, cell migration and invasion.
4. Mutation Function Research: By studying the mutation form of the MET gene, we understand its carcinogenic potential in different types of tumors and provide a molecular basis for the development of new anti-cancer strategies.
5. Cell Proliferation and Survival: Using the rapid proliferation characteristics of Ba/F3 cells, we studied the effects of MET receptor activation on cell proliferation and survival, revealing its key role in cancer cell growth, and providing a reference for related treatments.
A: Our Human MET stable cell line has undergone rigorous screening and verification to ensure stable expression of the MET gene. We verified the stability of the MET gene through PCR, Western blot and other methods, and conducted repeated tests at different time points and in different batches. Cells express MET under appropriate culture conditions and maintain stable expression levels.
A: Our Human MET stable cell line exhibits normal growth and proliferation properties on a BaF3 background. We provide detailed culture guidelines to help customers overcome the potential unique growth requirements of the BaF3 cell line. Customers are advised to pay close attention to cell growth during use and follow our culture recommendations.
A: Yes, our Human MET stable cell lines have passed strict quality control inspections. We verify cell lines according to international and internal standards, including stability of gene expression, cell morphology, contaminant detection, etc. We ensure that each batch of cell lines meets our quality standards to ensure our customers receive a high-quality product.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
This human MET stable cell line expresses very reliably in BaF3 cells. In my experiments, I observed that these cells stably expressed MET receptor tyrosine kinase and responded significantly to HGF binding. This process is of great significance to cell survival, embryonic development, migration and invasion. This cell line provides a reliable platform for studying the activity of the MET signaling pathway and the pathogenesis of related diseases.
Stable cell lines expressing human MET in BaF3 cells showed outstanding performance. It was observed that after these cells were stimulated by HGF, the MET receptor dimerized and was activated, triggering a series of signal transduction reactions. This provides an ideal model for us to study the role of the MET signaling pathway in biological processes such as cell migration and invasion, and helps us better understand the pathogenesis of related diseases.
The application of the human MET stable cell line in BaF3 cells has been very satisfactory. Through my experimental observations, these cells can stably express MET receptors and respond significantly to HGF binding. This provides an important tool for us to further study the role of the MET signaling pathway in malignant tumors such as hepatocellular carcinoma and head and neck tumors, and helps us find therapeutic targets for related diseases.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.